Status:
COMPLETED
Primary Prevention of Infection by COVID-19 in Workers
Lead Sponsor:
Unidad de Investigación Genética Molecular
Collaborating Sponsors:
Universidad de Antioquia
Conditions:
COVID
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Introduction: The SARS Co-2 contagious rate is high (Ro: 2.0-3.0). The infection is aggressive with high pathogenicity. Global confinement impacts all social and economic fields of human activity. Cli...
Detailed Description
RESEARCH QUESTION: Can the oropharyngeal spray of a viral blocking compound in conjunction with the provision of an immunostimulant emulsion, reduce the infection proportion by 2/3 ACTIVE PRINCIPLE I...
Eligibility Criteria
Inclusion
- Age between 18 and 60 years.
- Health care worker in the front line of care of suspected or confirmed cases of COVID-19.
- Negative IgM antibodies.
Exclusion
- Being a participant in another trial with another drug.
- Temperature above 38ºC.
- Having cohabited in the past 15 days with a person diagnosed with CoV-19.
- Pregnancy.
- Active o past smoker.
- Known hypersensitivity to drugs or food.
- History of respiratory disease.
- Underlying diseases (Hypertension, cancer, diabetes, cardiovascular disease, leukopenia).
- Signs or symptoms of CoV-19 infection: cough, dyspnea, myalgias.
Key Trial Info
Start Date :
March 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 5 2021
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT04420260
Start Date
March 18 2021
End Date
July 5 2021
Last Update
July 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beatriz Aristizabal
Medellín, Antioquia, Colombia, 050021